baber/WOPTO huggingface dataset:
Patent NZ-252209-A (NZ)
Title: Stabilised culture of proembryogenic cellular aggregates for use in vine regeneration techniques
Inventor: MAURO MARIE-CLAUDE
IPC: C12N5/04
Filed: 1993-05-11
Abstract: A stabilized culture of a proembryogenic cell line deposited under No. PL92042917 and variants and derived cultures having preserved comparable proembryogenic properties.
Patent NZ-253435-A (NZ)
Title: Medical grade port tubing: core layer of pvc, a tie layer and polymeric outer layer
Inventor: LO YING-CHENG
IPC: A61M1/28
Filed: 1993-05-12
Abstract: The present invention provides an improved coextruded medical port tubing. The medical port tubing provides characteristics that are desirable in the medical industry and therefore can be used as a medical port tubing in, for example, renal therapy or blood donor tubes. To this end, the present invention provides a coextruded medical grade port tubing comprising: an outer layer comprising a blend of polypropylene copolymer and styrene-ethylene-butylene-styrene copolymer; a tie layer; and a core layer comprising polyvinyl chloride.
Patent NZ-270737-A (NZ)
Title: Enteric coated tablet: active core, erodible polymer layer containing cellulose ether derivative, and enteric outer coating
Inventor: PHUAPRADIT WANTANEE
IPC: A61K9/22
Filed: 1995-03-17
Abstract: A novel delivery system for targeting drugs to the colon is comprised of three parts: (1) an enteric coating to prevent penetration of gastric fluid into the delivery system, thereby preventing any drug release in the stomach; (2) an erodible polymer layer which is exposed and gradually erodes during transit through the upper intestinal tract, and (3) a core, which is a conventional tablet or beadlet containing an active ingredient(s), which readily disintegrates and subsequently releases the drug to the target site, the colon, after erosion of the erodible polymer layer.
Patent NZ-272509-A (NZ)
Title: Tablet dispenser with dispensing mechanism settable to indicate variable start date in tablet dose sequence
Inventor: LAMBELET LAWRENCE E
IPC: B65D83/04
Filed: 1995-07-05
Abstract: This invention relates to a substantially circular tablet dispenser component system which may be adapted for a variable day start of a prescribed periodic tablet regimen. Also provided are a tablet dispenser kit, a tablet package adapted for filling the tablet dispenser system, methods of filling the tablet dispenser of the invention and methods of administering a prescribed regimen of medication using the tablet dispenser system of the invention. <MATH>
Patent NZ-289096-A (NZ)
Title: Extraction of iron ions from aqueous solution
Inventor: EHLE MICHAEL
IPC: C22B3/42
Filed: 1995-06-16
Abstract: Aminomethylene phosphinic acid derivs. contg. units of formula (I), soluble in hydrocarbons, or aminomethylene phosphonic acid derivs. contg. units of formula (Ia), or aminomethylene phosphonic acid derivs. of formula R<3>R<4>N-(A-N(R<5>))pR<6> (II), are used in the extn. of Fe ions from aq. solns. In the formulae: R<1> and R<2> = H, 1-30 C alkyl (opt. carrying up to 15 OH gps. and/or broken by up to 14 non-adjacent O atoms), or 2-30 C alkenyl, 7-18C aralkyl, or 6-14C aryl (opt. substd. with up to 3 1-12C alkyl or alkoxy, halogen, CN, OH or 1-4C alkoxycarbonyl; R<3>-R<6> = H, 1-30 C alkyl (opt. carrying up to 15 OH gps. and/or broken by up to 14 non-adjacent O atoms), 2-30 C alkenyl, 7-18C aralkyl, 6-14C aryl (opt. substd. with up to 3 1-12C alkyl or alkoxy, halogen, CN, OH or 1-4C alkoxycarbonyl), or are gps. of formulae -CR<1>R<2>-PO3H2, -CH2-COOH or -CH2-CH(OH)-R<1>; at least one of the gps. R<3>-R<6> = -CR<1>R<2>-PO3H2, and at least one other is 6-30C alk(en)yl, 7-18C aralkyl, (substd.) 6-14C aryl or -CH2-CH(OH)-R<9>; R<9> = 6-30 C alk(en)yl, 7-18C aralkyl or (substd.) 6-14 C aryl; A = 1-12C alkylene (opt. substd. with up to 3 1-30 C alkyl, 2-30C alkenyl, 7-18C aralkyl, or 6-14C aryl, which in their turn may be substd. by up to 3 1-12C alkyl or alkoxy, halogen, CN, OH, or 1-4C alkoxycarbonyl); and p = 0-30,000. Also claimed is a modifier for use in the sepn. of metal ions from aq. solns. by solvent extn..
Patent NZ-295682-A (NZ)
Title: Lipid cleavage enzyme complex and use in diagnostic testing to identify compounds that act as a ligand or substrate of the complex
Inventor: HERRMANN DIETER
IPC: A61K47/48
Filed: 1995-11-09
Abstract: A membranous enzyme not yet described in the state-of-the-art can be extracted from cellular membrane fractions of blood leukocytes or monocytes/macrophages. Also disclosed is the use of substrates of this enzyme to prepare medicaments that contain these substrates as pharmaceutical active substance. These medicaments are useful to direct pharmacologically active substances to target cells and to enrich target cells with said substances. Also disclosed are in-vitro research systems containing this enzyme used to detect other substrates of this enzyme.
Patent NZ-306663-A (NZ)
Title: Synthetic hpv6/11 hybrid l1 dna encoding human papilloma virus type 11 l1 protein
Inventor: HOFMANN KATHRYN J
IPC: A61K39/00
Filed: 1996-03-26
Abstract: PCT No. PCT/US96/04117 Sec. 371 Date Jan. 26, 1998 Sec. 102(e) Date Jan. 26, 1998 PCT Filed Mar. 26, 1996 PCT Pub. No. WO96/30520 PCT Pub. Date Oct. 3, 1996The present invention is directed to a synthetic DNA molecule encoding purified human papillomavirus type 11 L1 protein and derivatives thereof.
Patent NZ-315400-A (NZ)
Title: Pyridazin-3-one derivatives, their use, and intermediates for their production
Inventor: KATAYAMA TADASHI
IPC: A01N43/84
Filed: 1996-08-19
Abstract: his application relates to pyridazin-3-one derivatives of the formula (1) or (2), their use as herbicides and intermediates for production thereof.  In the compounds of formulae (1) and (2) the moiety Q is defined by the formulae as shown, R1 is C1-C3 haloalkyl, Y is halo, nitro, cyano or trifluoromethyl, X is H or halo and the other moieties are as defined in the specification.
Patent NZ-332244-A (NZ)
Title: Synthetic currency (inside money) transaction agent and network
Inventor: ENG ALVIN
IPC: G06Q20/00
Filed: 1997-04-11
Abstract: The specification describes a synthetic currency transaction network, as illustrated above,  which performs transactions with near real time finality of transaction between potential borrowers and potential lenders. Synthetic currency is created by pooling and dividing into shares a portfolio of highly liquid assets and frequent evaluation and disbursements of dividends on those assets.  This enables the assets to hold the value of the synthetic currency share at unity with the underlying currency. The synthetic currency network provides a way for interfacing users to the synthetic currency transaction network. A database is used for storing and maintaining records and other information of the network. A transaction manager manages network users' accounts and all network transactions. A fund accountant manages network information regarding the synthetic currency. A deposit bank acts as custodian for the portfolio of highly liquid assets which underlie the synthetic currency. An investment manager manages the measure of synthetic currency and directs investment decisions. A loan accountant manages all lending and borrowing activities in the synthetic currency transaction network
Patent NZ-334343-A (NZ)
Title: NMDA (n-methyl-d-aspartate) antagonists which preferentially bind to the strychnine-insensitive glycine binding site on the NMDA receptor complex
Inventor: HARRISON BOYD L
IPC: A61K31/404
Filed: 1997-08-18
Abstract: Excitatory amino acid antagonists of formula (1).  These antagonists are useful as NMDA (N-methyl-D-aspartate) antagonists and preferentially bind to the strychnine-insensitive glycine binding site on the NMDA receptor complex.  Also disclosed are pharmaceutical compositions containing these amino acid antagonists and the use of the composition to treat ischemic/hypoxic/hypoglycaemic damage to cerebral tissue and anxiety as well as being useful for producing an analgesic effect.
Patent NZ-336104-A (NZ)
Title: Non-peptide methylene carbonylamino derivatives that specifically inhibit the binding of ligands to VLA-4
Inventor: ADAMS STEVEN P
IPC: A61K31/00
Filed: 1996-01-18
Abstract: The non-peptide methylene carbonylamino derivatives or pharmaceutically acceptable salts or esters thereof have the formula (I) wherein: X is -CO2H, -PO-3H, -SO2R5, -SO3H, -OPO-3H or -CO2R4; Y is -CO-, -SO2- or PO2-; R1 is aryl-alkenyl, aryl-alkynyl, alkenyl, alkynyl, cycloalkyl, aryl-fused cycloalkyl, cycloalkenyl, aryl, aralkyl, cycloalkyl-alkyl, cycloalkenyl-cycloalkyl, bi-aryl, alkoxy, alkenyloxy, alkynyloxy, aralkoxy, aryl-alkenyloxy, aryl-alkynyloxy, alkylamino, alkenylamino, alkynylamino, aryl-alkylamino, aryl-alkenylamino, aryl-alkynylamino, aryloxy, arylamino, N-alkylurea-alkyl, N-arylurea-alkyl, alkylcarbonylamino-alkyl, aminocarbonyl-alkyl, heterocyclyl, heterocyclyl-alkyl, heterocyclyl-amino, carboxyalkyl-aralkyl, oxocarbocyclyl-fused aryl or heterocyclylalkyl provided that R1 cannot be t-butoxy or benzyloxy; R2 is hydrogen, aryl, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl or aralkyl or R2 and R3 together with the atoms to which they are attached can form a heterocycle; R3 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aralkyl, aryl-alkenyl, aryl-alkynyl, hydroxy-alkyl, alkoxy-alkyl, aralkoxy-alkyl, amino-alkyl, (aryl-alkyloxycarbonylamino) alkyl, thio-alkyl, alkylsulphonyl-alkyl, (hydroxy-alkylthio) alkyl, thioalkoxy-alkyl, acylamino-alkyl, alkylsulphonylamino-alkyl, arylsulphonylamino-alkyl, morpholino-alkyl, thiomorpholino-alkyl, morpholinocarbonyl-alkyl, thiomorpholinocarbonyl-alkyl, [N-(alkyl, alkenyl or alkynyl)- or N,N-[dialkyl, dialkenyl, dialkynyl or (alkyl, alkenyl)-amino] carbonyl-alkyl, carboxy-alkyl, dialkylamino-acylaminoalkyl or amino acid side chains selected from arginine, asparagine, glutamine, S-methyl cysteine, methionine or corresponding sulphoxide or sulphone derivatives thereof, glycine, leucine, isoleucine, allo-isoleucine, tert-leucine, norleucine, phenylalanine, tyrosine, tryptophan, proline, alanine, ornithine, histidine, glutamine, valine, threonine, serine, aspartic acid, beta-cyanoalanine and allothreonine; R4 is aryl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aralkyl, hydrogen, heterocyclyl, heterocyclylcarbonyl, aminocarbonyl, amido, mono- or dialkylaminocarbonyl, mono- or diarylaminocarbonyl, alkylarylaminocarbonyl, diarylaminocarbonyl, mono- or diacylaminocarbonyl, aromatic or aliphatic acyl or optionally substituted alkyl; R5 is aralkyl, aryl-alkenyl, aryl-alkynyl, aryl, alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkenyl and n is 0, 1 or 2; provided that when R1 is N-alkylurea alkyl or N-arylurea alkyl and Y is CO, R3 is not 3-indolylmethyl. A pharmaceutical composition thereof is useful for preventing, inhibiting or suppressing of cell adhesion.
Patent NZ-509437-A (NZ)
Title: Slip resistant buckle with two bars forming pinch point and third bar to maintain tension when buckle rotated
Inventor: HAMILTON JEFFREY R
IPC: A44B11/00
Filed: 2001-01-17
Abstract: Buckle 10 has first and second lacing bars 32, 34 forming a pinch point, and a third lacing bar 36 which maintains the pinch point during rotation of the buckle.
Patent NZ-512511-A (NZ)
Title: A latch and method of mounting same
Inventor: FOUNTAINE HOWARD JOHN
IPC: E05B1/00
Filed: 2001-06-20
Abstract: A latch device includes a body which incorporates a moveable latch element (11) which is movable between a latching position and a non-latching position, the body also has a moving mechanism (22) for moving the latch element between said latching and non-latching positions. The latch device further includes a snap lock means (44, 45, 46, 47) to lock the body and a separate mounting member in a fixed position relative to one another in a window extrusion whereby the operating element is accessible externally of the window extrusion to operate the moving mechanism.
Patent NZ-518554-A (NZ)
Title: 6-methoxy-2-naphthylacetic acid prodrugs
Inventor: EKWURIBE NNOCHIRI N
IPC: A61K31/167
Filed: 2000-10-27
Abstract: Described are compounds of formula I that are prodrugs of 6-methoxy-2-naphthylacetic acid (6MNA), for which the substituents are defined herein. The compounds are used in the manufacture of medicaments for treating inflammation.
Patent NZ-519248-A (NZ)
Title: A building structure utilising modular building elements
Inventor: HARAMBASIC BAHRA
IPC: A63H33/08
Filed: 2000-11-29
Abstract: A  building  structure formed  from  modular  building elements, which include first modular building elements  (1, 9)  having  socket  beam interconnection means  (2),  second modular building elements (13, 14, 15) and socket beams  (7, 11)  having  first modular building element  interconnection means   (6);  whereby  a  socket  beam  (7,  11)  forms   an interconnection  with  at least one first  modular  building element  (1,  9),  and at least one second modular  building element  (13, 14, 15) associates with a socket beam (7,  11) and  first  modular  building  element  interconnection,   a socket  beam (7, 11) and at least one first modular building element  (1,  9)  and at least one second  modular  building element  (13,  14,  15)  forming a configuration  unit,  the configuration unit being repeatable one atop the other,  and being  repeatable in a side-by-side fashion, a first modular building  element  associating  or  abutting  with  adjacent first  modular building elements, a second modular  building element   associating  or  abutting  with  adjacent   second modular  building elements and a socket beam associating  or abutting with adjacent socket beams.
Patent NZ-527501-A (NZ)
Title: Methods of generating modified proteins that are shorter and/or less antigenic polypeptides
Inventor: ROSENBLUM MICHAEL G
IPC: A61K35/76
Filed: 2002-02-12
Abstract: A modified enzyme produced by a process that comprises identifying one or more antigenic regions in the enzyme using an antibody, removing one or more antigenic regions from the enzyme and determining that the modified enzyme has enzymatic activity. The enzyme used is humanized recombinant gelonin toxin. The modified enzyme, which has reduced antigenicity, can be used in the preparation of a medicament for the treatment of cancer.
Patent NZ-533750-A (NZ)
Title: N-Pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
Inventor: BAXTER ANDREW
IPC: A61P17/04
Filed: 2003-01-14
Abstract: Disclosed is a compound of formula (I) wherein: R1, R2 and R3 are independently H, halogen, cyano, CF3, OCF3, OC1-6 alkyl or C1-6 alkyl; R4 is halogen, CO2R12, C1-6 alkoxy, C3-6 alkenoxy, C3-6 alkynoxy, OC1-6 alkyl-X-C1-6, OC1-6 alkylR11, OC1-6 alkylR16,, optionally substituted as defined; R5 and R6 are independently H, cyano, halogen, CO2R12, CONR14R15, C1-6 alkyl, C1-6 alkylR11 , XCH(R11) C1-6 , XCH(R16)C1-6 alkyl, NR14R15, N(R11)R11, X-(CH2)qNR14R15, (CH2)nNR14R15, C3-6 alkynyl or alkenyl, or as defined; and R11, R12, R14, R15, R16, n, q and X are as defined. Where the compound of formula (I) is used in the treatment of cytokine mediated diseases including asthma, arthritis, psoriasis, dermatitis, neurodegenerative diseases, hepatitis and cancer.
Patent NZ-542132-A (NZ)
Title: Concrete block and method of making same
Inventor: SCHERER RONALD J
IPC: B28B7/10
Filed: 2004-01-29
Abstract: Methods for making concrete blocks with patterned front faces and methods for making the moulds that form the blocks in high-speed, mass production processes are disclosed. The concrete block 10 is formed using dry cast concrete compacted in a mould cavity. The mould is shaped so that a three-dimensional pattern is formed on the front face 12 of the block. The pattern is formed by digitally scanning a selected three-dimensional pattern, either from a natural or man-made object, and creating a mould surface in the mirror image of the pattern.
Patent NZ-549487-A (NZ)
Title: Removable module making electrical contact with drill control system on assembly, for controlling functions such as drilled depth
Inventor: JEGANATHAN BALU
Filed: 2006-08-28
Abstract: An electric drill is disclosed that is provided with an interchangeable module to control one or more functions associated with operation of the drill. The module is mounted on an external part of the drill, typically just behind the chuck, and is operatively connected to a control system of the drill by engagement of electrical contacts on the module with electrical contacts on the part of the drill that the module engages.
Patent NZ-549492-A (NZ)
Title: Bone fixation means
Inventor: DUTOIT CHRISTOF
IPC: A61B17/68
Filed: 2004-03-03
Abstract: Bone fixation means 1 comprising A) a longitudinal shaft 2 with a longitudinal axis 3 and B) an anchoring element 4 with the identical longitudinal axis 3, which can be fastened axially to the shaft 2 and fixed in a bone, characterized in that C) interacting means are provided at the shaft 2 and at the anchoring element 4 and alternatively permit or block rotation of the anchoring element 4 about the longitudinal axis 3 relative to the shaft 2, whereby D) axial locking-in-position means are disposed at the shaft 2 and at the anchoring element 4, by means of which the shaft 2 and the anchoring element 4 are held together axially, and E) the actions of the axial locking-in-position means and the interacting means are independent of one another.
Patent NZ-562311-A (NZ)
Title: Buccal delivery system
Inventor: HEWITT ERNEST ALAN
IPC: A61K9/20
Filed: 2006-04-07
Abstract: Disclosed is a buccal delivery system capable of being blended in a normal dry powder process and compressed using a standard tabletting machine, said buccal delivery system comprising a matrix of: a) an effective amount of one or more active ingredients; b) an amount of one or more polyethylene glycols or derivatives thereof having a molecular weight between 1000 to 8000 sufficient to provide the required hardness and time for dissolution of the matrix; c) 0.05-2% by weight of the total matrix of one or more suspending agents; d) 0.05-2% by weight of the total matrix of one or more sweeteners.
Patent NZ-570095-A (NZ)
Title: Quick-drying cosmetic emulsions for roll-on application
Inventor: TECKENBROCK GERTRAUD
IPC: A61Q90/00
Filed: 2007-04-24
Abstract: Disclosed is a cosmetic oil-in-water emulsion that does not represent a microemulsion, containing 0.5 to 6.5 w percent oil phase or fat phase, encompassing at least one oil component that is liquid at 20 degrees C, selected from i) linear and branched saturated mono- or polyvalent alkanols that are etherified with at least one propylene oxide unit per molecule, ii) propylene glycol monoesters of branched saturated alkanecarboxylic acids, iii) branched saturated alkanols, b) at least 60 wt percent water, c) 0.00001 to 38 wt percent of at least one cosmetic active substance selected from perspiration-inhibiting active substances, deodorizing active substances, monomers, oligomers, and polymers of amino acids, acylamino acids, the esters and/or the physiologically compatible salts of said substances, DNA or RNA oligonucleotides, natural betaine compounds, vitamins, provitamins, and vitamin precursors of groups A, B, C, E, H, and K, and the esters of the aforesaid substances, alpha-hydroxycarboxylic acids, alpha-ketocarboxylic acids, beta-hydroxycarboxylic acids, and their ester, lactone, or salt form, flavonoids and flavonoid-rich plant extracts, isoflavonoids and isoflavonoid-rich plant extracts, polyphenols and polyphenol-rich plant extracts, ubiquinone and ubiquinol, and derivatives thereof, silymarin, ectoin, repellents, inorganic and organic UV-filtering substances, self-tanning active substances, skin-lightening active substances, skin-calming active substances, moisture-donating active substances, sebum-regulating active substances, wherein at least one perspiration-inhibiting active substance is present, d) at least one polysaccharide, such as starch, wherein the at least one polysaccharide is contained in a total quantity from 0.01 to 0.2 wt percent, based on the total weight of the emulsion, e) at least one nonionic emulsifier f) at least one nonionic emulsifier, selected from Steareth, Ceteth, Myristeth, Laureth, Trideceth, Arachideth, and Beheneth, having respectively 7 to 40 ethylene oxide units per molecule in a total quantity from 1 to 2 wt percent, based on the weight of the entire emulsion.
Patent NZ-574247-A (NZ)
Title: Pool cleaner debris bag with a securing means
Inventor: GOPALAN SURESH CHERULASSERY
IPC: E04H4/16
Filed: 2007-06-19
Abstract: A pool cleaner debris bag (10) is disclosed. The bag comprises, a porous material (14) defining an interior cavity, which has a closable first end (22) and a second end (23). The second end is adapted to attach to a pool cleaner for receiving debris from a pool ejected by the pool cleaner into the bag. A snap plate (34) is coupled to a first side of the porous material adjacent to the closable first end. A hinge plate is coupled to a second side of the porous material adjacent to the closable first end. A clasp (36) is attached to the bag at the closable first end to permit closure of the closable first end. The clasp includes at least one projection received by the snap plate, and the clasp includes a hinge portion coupled to the hinge plate. A substantially rigid liner is coupled to the snap plate and the hinge plate with a plurality of attachment members.
Patent NZ-583529-A (NZ)
Title: Ergometric training device with a measuring system to measure the angular position of the sprocket
Inventor: ADAMOVIC DUSAN
IPC: A63B22/08
Filed: 2008-08-28
Abstract: Disclosed is a stationary ergometric exercise device (10), having a manually/foot operated drive with two drive elements (16) that can be alternately operated, with the drive joined to a flywheel by means of a gear mechanism. The exercise device further has a measuring means for measuring the driving force applied by the drive or the torque force associated with each of the drives. The measuring means comprises a measuring arrangement for measuring the angular position of the drive, having a pair of sensor means which are disposed in mutually opposed positions with respect to a wheel connected to the drive such that the motions are synchronized, the positions each corresponding to a position of motion of a load change between the two drive elements (16). A computer device can receive the signals from the force measuring means and calculate with them the chronological sequence of the driving force, or the torque force, and variables that can be derived from them.
Patent NZ-583640-A (NZ)
Title: Charcoals
Inventor: DE LEIJ FRANCISCUS ANTONIUS ANNA MARIA
IPC: B09C1/10
Filed: 2008-07-31
Abstract: A method of preparing an ion exchange agent for adsorbing cations is disclosed, wherein the method comprises charring non-woody plant material to produce charred material, wherein the charring comprises heating the non-woody plant material to a temperature of between 300 Deg. C and 700 Deg. C, wherein the ash content of the charred material is at least 15% (by weight), and wherein K, Ca, Mg, Mn and/or P make up at least 10% of the charred material weight. This ion exchange agent is suitable for the removal or binding of cationic species in an environment wherein the cationic species may be one or more metal species, and the environment may be selected from soil, solid waste, a slurry or an aqueous waste, and wherein the treatment of the environment is effected by trapping the agent in a vehicle and passing a liquid over or through the vehicle, thereby to contact the trapped charred material and permit removal of some or all of the contaminating cations. Said is also suitable to remove a cationic dye from a solution such as a waste stream.